OptiRTP Presents to S&C Practitioners at Inaugural NZSCA-SPRINZ Conference
Mal Geluk, Jon Doherty, Monalisa Codling, Keven Mealamu, Amber Kuys-Clarke, Byron Thomas, Matt Blair
OptiRTP presented its Optimum Bio Sound Therapy (OBST) platform to approximately 50–60 strength and conditioning coaches, sport scientists, medical professionals, and academics at the inaugural NZSCA-SPRINZ Strength & Conditioning Practitioners Day on 18 November 2025.
The event, held at Massey University’s Albany Campus, was organised by the New Zealand Strength & Conditioning Association (NZSCA) under Sports & Exercise Science New Zealand (SESNZ) in partnership with the Sports Performance Research Institute New Zealand (SPRINZ).
OptiRTP was a principal sponsor of the practitioners day. Byron Thomas, Partnerships and Performance Manager, delivered a 45-minute presentation on the platform’s integration into high-performance recovery environments.
Former All Blacks hooker Keven Mealamu (132 test caps, two-time Rugby World Cup winner) and former Black Ferns lock Monalisa Codling (30 test caps, four-time Rugby World Cup winner) spoke about their experiences using the platform.
About OptiRTP
OptiRTP (Return to Play) is a New Zealand-based biotech company. Its core technology, OBST (Optimum Bio Sound Therapy), has 352,000+ documented therapy hours with zero serious adverse events reported. OBST is an FDA-registered Class I medical device, 510(k)-exempt (registration and listing, not FDA clearance or approval), that uses dynamic, patterned acoustic neuromodulation via the auditory pathway, with a proposed mechanism involving modulation of central autonomic regulatory networks associated with sleep, pain, recovery and stress regulation. Drug-free and non-invasive, used passively during sleep or rest through a tablet and earbuds. Users can follow recovery markers on their own wearable.
